The top priority of many sponsors is to ensure that their clinical trials are low-risk and deliver high-quality data as quickly as possible. With this in mind, Metronomia aims to provide customers with next-level service, support and flexibility, delivering specialized biometrics expertise tailored to their unique needs. Deploying Medidata Rave
EDC gives its customers an advanced, robust and secure platform that is trusted to deliver accurate results.

The Metronomia-Medidata collaboration empowers us to support biotech and pharmaceutical innovators under tight timelines and resource constraints. With Medidata’s scalable and flexible platform, coupled with Metronomia’s biometrics expertise, we’re helping clients mitigate risks and optimize their clinical trial outcomes.

Read the full article here.